GlassScriptPhysician profile
Jon Bradley Johnson
NPI 1629014626
$1,609.78
in general payments reported to CMS, 2019-2025
21 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.24 · 2020: $59.25 · 2021: $290 · 2022: $334 · 2023: $287 · 2024: $183 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $530.92 | 2019-2024 | Veozah, Myrbetriq |
| Valencia Technologies Corporation | $223.69 | 2025 | Ecoin Device Kit |
| Urovant Sciences INC | $167.24 | 2021-2022 | |
| Urogen Pharma, INC. | $115.53 | 2023-2025 | Jelmyto |
| Coloplast Corp | $104.94 | 2021-2023 | Porges Coloplast |
| C. R. Bard, INC. & Subsidiaries | $83.83 | 2023-2025 | Bard Urinary Drainage Bag |
| Rochester Medical Corporation | $41.83 | 2021-2022 | |
| Hollister Incorporated | $40.20 | 2022-2023 | Infyna Chic |
| Pfizer INC. | $36.43 | 2020-2025 | |
| Amgen INC. | $36.19 | 2023 | Prolia |
| Progenics Pharmaceuticals, INC. | $33.41 | 2023-2024 | Pylarify |
| Novo Nordisk INC | $28.15 | 2023-2024 | Ozempic, Rybelsus |
| Myriad Genetic Laboratories, INC. | $24.31 | 2024 | Prolaris |
| Laborie Medical Technologies Corp. | $23.95 | 2023 | |
| Antares Pharma, INC. | $20.60 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $20.32 | 2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $18.72 | 2019 | |
| Janssen Biotech, INC. | $17.27 | 2024 | Erleada |
| Endo USA, INC. | $16.08 | 2025 | Xiaflex, Aveed |
| Abc Home Medical Supply, INC. | $15.11 | 2022 | |
| 180 Medical, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.